Oversold stocks

Search documents
Here's Why Frontier Group (ULCC) is Poised for a Turnaround After Losing -31.11% in 4 Weeks
ZACKS· 2025-03-24 14:35
Group 1 - Frontier Group Holdings (ULCC) has experienced significant selling pressure, resulting in a stock price decline of 31.1% over the past four weeks, but it is now considered to be in oversold territory with potential for better earnings than previously predicted by analysts [1] - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2] - The RSI reading for ULCC is currently at 23.73, suggesting that the heavy selling may be exhausting itself and a price reversal could occur soon [5] Group 2 - Analysts have raised earnings estimates for ULCC by 0.4% over the last 30 days, indicating a positive trend that often leads to price appreciation [6] - ULCC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [7]
After Plunging -28.17% in 4 Weeks, Here's Why the Trend Might Reverse for Genasys (GNSS)
ZACKS· 2025-03-07 15:36
Group 1 - Genasys (GNSS) has experienced a significant decline of 28.2% over the past four weeks, but it is now in oversold territory, indicating a potential trend reversal [1] - The Relative Strength Index (RSI) for GNSS is currently at 27.66, suggesting that the heavy selling pressure may be exhausting itself [5] - There is a strong consensus among Wall Street analysts that GNSS will report better earnings than previously predicted, with a 17.1% increase in the consensus EPS estimate over the last 30 days [6] Group 2 - GNSS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a potential turnaround [7]
Down -31.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Relay Therapeutics (RLAY)
ZACKS· 2025-03-05 15:36
Core Viewpoint - Relay Therapeutics, Inc. (RLAY) has experienced a significant decline of 31.1% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from Wall Street analysts [1]. Group 1: Stock Performance and Technical Indicators - RLAY's stock has been under heavy selling pressure, leading to an RSI reading of 26.89, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Earnings Estimates and Analyst Consensus - There is a strong consensus among sell-side analysts that RLAY will report better earnings than previously predicted, with a 14.1% increase in the consensus EPS estimate over the last 30 days [6]. - RLAY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a near-term turnaround [7].
Down -16.01% in 4 Weeks, Here's Why You Should You Buy the Dip in Paypal (PYPL)
ZACKS· 2025-02-26 15:36
Core Viewpoint - Paypal (PYPL) has experienced significant selling pressure, resulting in a 16% decline in stock price over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2]. - PYPL's current RSI reading is 28.86, suggesting that the heavy selling may be exhausting, which could lead to a price rebound as it seeks to return to equilibrium [5]. Group 2: Fundamental Indicators - Analysts have raised earnings estimates for PYPL by 2.3% over the last 30 days, indicating a consensus among sell-side analysts that could lead to price appreciation [6]. - PYPL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which further supports the potential for a near-term turnaround [7].